A post-marketing surveillance study of efficacy and safety of abiraterone acetate plus prednisolone in patients with castration-resistant prostate cancer
Latest Information Update: 14 Dec 2021
At a glance
- Drugs Abiraterone acetate (Primary) ; Prednisolone (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 14 Dec 2021 New trial record